GLOBAL EXPERT

TRUSTED PARTNER

Intsel Chimos is your all in one pharmaceutical company with exploitant status in compliance with the French Public Health Code. We support our partners in accessing the market for products under compassionate use, early access as well as marketing authorization of registered products. We are offering comprehensive expertise across the entire product life cycle:

Intsel Chimos specializes in facilitating both early and market access providing comprehensive support to pharmaceutical companies introducing therapies into the French healthcare system — before and also after marketing authorization.

Additionally Intsel Chimos can assist your data collection and product distribution within the framework of clinical trials.

Benefits of working with Intsel Chimos
Intsel Chimos offers a comprehensive and integrated approach to help pharmaceutical companies navigate the complex regulatory and market landscape. Key benefits include:

  • Integrated Services: From pharmacovigilance and quality assurance to strategic sales and marketing support, we ensure seamless products management and successful strategies.
  • Customized Strategies: Regulatory, pricing, and reimbursement solutions designed to align with your specific product and market objectives.
  • Continuity of Access: Full lifecycle management—from early access programs to post-Marketing Authorization support — ensuring consistent patient access to treatments.
  • Compliance Excellence: Strict adherence to national and international standards (e.g., GVP, GMP, GDP, French Public Health Code) to ensure data integrity and sustained compliance.
  • Operational Efficiency: Optimized timelines to accelerate market entry, in-house storage and distribution to secure the supply chain.
  • Cross-therapeutic Expertise: Deep experience across multiple therapeutic areas including but not limited to rare diseases.

COMMITMENT

EFFICIENCY AND RELIABILITY

As a distinguished distributor and operator of
compassionate and/or early access medicines
(AAC/AAP), we provide solutions to patients whose
needs are unmet by treatments currently unavailable in the French
market.

COMPLIANCE AND LIABILITY

Intsel Chimos has acquired in-depth knowledge and
familiarity with the French and European healthcare
systems. We are fully dedicated to supporting our
parthers in navigating these systems successfully across
all therapeutic areas.

REACTIVITY AND FLEXIBILITY

Intsel Chimos has developed expertise that allows it to
be reactive and flexible in the acquisition and
distribution or various pharmaceutical specialties to
hospitals and community pharmacies.

Plan de travail 79 EN

As a pharmaceutical company, Intsel Chimos is committed to supporting it’s partners success at all stages : registration, marketing, and promotion of treatments. We aim to accomplish this in the simplest and most efficient way possible, while maintaining strict compliance with the French and European regulations.

PRODUCTS

Intsel Chimos holds exploitant status across various therapeutic areas from niche products to higner volumes in order to provide a comprehensive offer to hospitals and pharmacies. We manage a portfolio of over 80 products operated under Early Access and Commercial Use.

THERAPEUTIC AREAS

Do you have a question ?

contact@intselchimos.com
+33 1 49 11 66 80
Contact Us
CONTACT